1.90
price up icon1.06%   0.02
 
loading
Schlusskurs vom Vortag:
$1.88
Offen:
$1.88
24-Stunden-Volumen:
570.57K
Relative Volume:
0.59
Marktkapitalisierung:
$59.00M
Einnahmen:
$8.59M
Nettoeinkommen (Verlust:
$-17.07M
KGV:
-3.1148
EPS:
-0.61
Netto-Cashflow:
$-21.90M
1W Leistung:
+0.00%
1M Leistung:
+254.94%
6M Leistung:
+134.57%
1J Leistung:
+42.86%
1-Tages-Spanne:
Value
$1.86
$1.90
1-Wochen-Bereich:
Value
$1.86
$1.92
52-Wochen-Spanne:
Value
$0.4801
$2.64

Durect Corp Stock (DRRX) Company Profile

Name
Firmenname
Durect Corp
Name
Telefon
(408) 777-1417
Name
Adresse
10240 BUBB ROAD, CUPERTINO, CA
Name
Mitarbeiter
14
Name
Twitter
@DURECTCorp
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
DRRX's Discussions on Twitter

Vergleichen Sie DRRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
DRRX
Durect Corp
1.90 59.00M 8.59M -17.07M -21.90M -0.61
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.76 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.48 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.91 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.61 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
306.48 14.21B 2.99B 1.21B 1.13B 25.06

Durect Corp Stock (DRRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-10-30 Eingeleitet Chardan Capital Markets Buy
2020-10-12 Eingeleitet ROTH Capital Buy
2020-07-31 Eingeleitet Oppenheimer Outperform
2020-01-31 Eingeleitet B. Riley FBR Buy
2019-11-18 Fortgesetzt Cantor Fitzgerald Overweight
2019-09-06 Eingeleitet Cantor Fitzgerald Overweight
2018-03-06 Hochstufung H.C. Wainwright Neutral → Buy
2017-10-20 Herabstufung H.C. Wainwright Buy → Neutral
2017-10-20 Bestätigt Laidlaw Buy
2017-10-20 Herabstufung Stifel Buy → Hold
2017-07-12 Hochstufung Stifel Hold → Buy
2017-02-28 Fortgesetzt H.C. Wainwright Buy
2016-04-25 Eingeleitet Rodman & Renshaw Buy
2015-05-01 Bestätigt Cantor Fitzgerald Buy
2015-05-01 Bestätigt Stifel Buy
2013-03-25 Eingeleitet Stifel Buy
2012-11-01 Herabstufung C.K. Cooper Buy → Hold
2012-08-17 Eingeleitet C.K. Cooper Buy
2009-06-23 Eingeleitet Caris & Company Buy
2009-03-26 Eingeleitet Wedbush Morgan Hold
Alle ansehen

Durect Corp Aktie (DRRX) Neueste Nachrichten

pulisher
Aug 20, 2025

Is DURECT Corporation stock reversal real or fake2025 Performance Recap & Weekly High Momentum Picks - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Published on: 2025-08-20 01:19:24 - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Using R and stats models for DURECT Corporation forecastingTrade Performance Summary & High Win Rate Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Will DURECT Corporation continue its uptrend2025 Volatility Report & Weekly High Momentum Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can swing trading help recover from DURECT Corporation losses2025 Institutional Moves & Growth Focused Entry Point Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using data tools to time your DURECT Corporation exitEarnings Summary Report & Breakout Confirmation Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Sentiment analysis tools applied to DURECT CorporationPortfolio Update Summary & Smart Investment Allocation Insights - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

DURECT (NASDAQ:DRRX) Stock Price Passes Above 200 Day Moving Average – Here’s What Happened - Defense World

Aug 19, 2025
pulisher
Aug 17, 2025

What does recent volatility data suggest for DURECT CorporationTrade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Reversal indicators forming on DURECT Corporation stock2025 Trading Recap & Daily Entry Point Trade Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Technical signs of recovery in DURECT CorporationPortfolio Return Report & Community Trade Idea Sharing - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Market reaction to DURECT Corporation’s recent newsJuly 2025 Sector Moves & Free Community Supported Trade Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Signal strength of DURECT Corporation stock in tech scannersMarket Performance Summary & Proven Capital Preservation Tips - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Chart based exit strategy for DURECT CorporationDip Buying & Low Drawdown Trading Techniques - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

When is the best time to exit DURECT CorporationPortfolio Value Summary & Accurate Buy Signal Alerts - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Durect 2025 Q2 Earnings Net Loss Narrows by 38.8% - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

DURECT Corporation Reversal Rally May Surprise BearsQuarterly Market Summary & Short-Term Trading Opportunity Alerts - sundaytimes.kr

Aug 13, 2025
pulisher
Aug 13, 2025

Durect: Q2 Earnings Snapshot - Connecticut Post

Aug 13, 2025
pulisher
Aug 12, 2025

Published on: 2025-08-12 20:28:09 - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Using economic indicators to assess DURECT Corporation potentialJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Bausch Health's Durect Acquisition: Strategic Valuation and Risk Mitigation in Biopharma M&A - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Durect (DRRX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

DRRX 8-K: Announces Q2 2025 Financial Results Under Regulation FD - Stock Titan

Aug 12, 2025
pulisher
Aug 12, 2025

Biotech DURECT Gets $63M Buyout Offer from Bausch Health with $350M Future Payment Potential - Stock Titan

Aug 12, 2025
pulisher
Aug 12, 2025

Why DURECT Corporation stock attracts strong analyst attentionPredictive Analytics for Equity Growth Potential - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

How is DRRX performing? - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Is DURECT Corporation reversing from oversold territoryFree Daily Top Performing Stock Insights - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

DURECT (DRRX) Projected to Post Quarterly Earnings on Tuesday - Defense World

Aug 10, 2025
pulisher
Aug 09, 2025

Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - Insider Monkey

Aug 09, 2025
pulisher
Aug 09, 2025

Durect Extends Tender Offer Deadline in Merger with Bausch Health. - AInvest

Aug 09, 2025
pulisher
Aug 04, 2025

Visualizing DURECT Corporation stock with heatmapsDay Trading Plan with Entry Risk Management - Newser

Aug 04, 2025
pulisher
Aug 02, 2025

What is DURECT Corporation company’s growth strategyFree Investment Community - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

Can volume confirm reversal in DURECT CorporationSmart Forecast Signals from AI Models - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders - Eastern Progress

Aug 01, 2025
pulisher
Aug 01, 2025

What makes DURECT Corporation stock price move sharplyRisk/Reward Optimization Entry Point Analysis - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Does DURECT Corporation show high probability of reboundMarket Correction Proof Stock Screening Analysis - Newser

Jul 31, 2025

Finanzdaten der Durect Corp-Aktie (DRRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$28.97
price up icon 0.42%
$17.46
price down icon 0.34%
drug_manufacturers_specialty_generic RDY
$14.13
price down icon 0.35%
$10.65
price down icon 0.28%
$133.23
price up icon 0.32%
$306.48
price down icon 2.15%
Kapitalisierung:     |  Volumen (24h):